Estimation of Renal Function - What is Appropriate in Cancer Patients?

Clinical Oncology

Volumn 20, Issue 10, 2008, Pages 721-726

  Barraclough, L H ^a   Field, C ^a   Wieringa, G ^a   Swindell, R ^a   Livsey, J E ^a   Davidson, S E ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Cancer; estimated GFR; glomerular filtration; radioisotope GFR; renal function assessment

Indexed keywords

CREATININE; PENTETATE TECHNETIUM TC 99M;

ACCURACY; ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIGESTIVE SYSTEM CANCER; FEMALE; GERM CELL TUMOR; GLOMERULUS FILTRATION RATE; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; INTERMETHOD COMPARISON; ISOTOPE LABELING; KIDNEY FUNCTION TEST; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOLID TUMOR; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CHLORIDES; CHROMIUM COMPOUNDS; CHROMIUM RADIOISOTOPES; CREATININE; DIET; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NEOPLASMS; REGRESSION ANALYSIS; ROC CURVE; YOUNG ADULT;

EID: 55149103533     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.09.004     Document Type: Article

References (25)

1. Dubovsky E.V., and Russell C.D. Quantification of renal function with glomerular and tubular agents. Semin Nucl Med 12 (1982) 308-329
2. Rehling M., Moller M.L., Thamdrup B., et al. Simultaneous measurement of renal clearance and plasma clearance of 99m Tc labelled DTPA, 51 Cr labelled EDTA and inulin in man. Clin Sci (London) 66 (1984) 613-619
3. Rapoport A., and Husdan H. Endogenous creatinine clearance and serum creatinine in the clinical assessment of kidney function. Can Med Assoc J 99 (1968) 149-156
4. Buchler M., Bretagnol A., Desaldeleer P., et al. Estimation of the glomerular filtration rate through different methods in kidney transplant recipients: correlation with the creatinine clearance measurement. Transplant Proc 39 (2006) 2289-2291
5. Gabriel R. Time to scrap the creatinine clearance?. Br Med J 293 (1986) 1119-1120
6. Cockroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
7. Levey A.S., Bosch J.P., Breyer Lewis J., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130 (1999) 461-670
8. Department of Health. Estimating glomerular filtration rate - information for laboratories. Available from: (April 2006). http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4133024
9. UK National External Quality Assessment Service for GFR estimations. Available from: (March 2006). www.ukneqas.org.uk
10. Giles P.D., and Fitzmaurice D.A. Formula estimation of glomerular filtration rate: have we gone wrong?. Br Med J 334 (2007) 1198-1200
11. Tomson C.R.V., Lamb E.J., Griffith K., et al. Time to move forward. Br Med J 335 (2007) 111-112
12. Rule A.D., Larson T.S., Bergstralh E.J., et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 141 (2004) 929-937
13. Wright J.G., Boddy A.V., Highley M., et al. Estimation of glomerular filtration rate in cancer patients. Br J Cancer 84 (2001) 452-459
14. Waller D.G., Juer L., and Fleming J.S. Measurement of glomerular function during cisplatin therapy. Br J Clin Pharmac 31 (1991) 271-274
15. Launay-Vacher V., Oudard S., Janus N., et al. Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management. Cancer 110 (2007) 1376-1384
16. Kleber M., Cybulla M., Bauchmüller K., et al. Monitoring of renal function in cancer patients: an ongoing challenge for clinical practice. Ann Oncol 18 (2007) 950-958
17. Séronie-Vivien S., Toullec S., Malard L., et al. Contribution of the MDRD equation and of cystatin C for renal function estimates in cancer patients. Med Oncol 23 1 (2006) 63-74
18. Tsubaki T., Goodwin S., Leader W.G., et al. Estimation of creatinine clearance in patients with gynaecologic cancer. Clin Pharm 12 (1993) 685-690
19. Stabuc B., Vrhovec L., Stabuc-Silih M., et al. Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy. Clin Chem 46 2 (2000) 193-197
20. Benöhr P., Grenz A., Hartmann J.T., et al. Cystatin C - a marker for assessment of the glomerular filtration rate in patients with cisplatin therapy. Kidney Blood Press Res 29 1 (2006) 32-35
21. Kos J., Stabuc B., Cimerman N., et al. Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem 44 12 (1998) 2556-2557
22. Robinson B.A., Frampton C.M., Colls B.M., et al. Comparison of methods of assessment of renal function in patients with cancer treated with cisplatin, carboplatin or methotrexate. Aust NZ J Med 20 (1990) 657-662
23. Martin L., Chatelut E., Boneu A., et al. Improvement of the Cockroft-Gault equation for predicting glomerular filtration in cancer patients. Bull Cancer 85 (1998) 631-636
24. De Lemos M.L., Hseih T., Hamata L., et al. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynaecological malignancies. Gynecol Oncol 103 3 (2006) 1063-1069
25. Calvert A.H. A review of the pharmacokinetics and pharmacodynamics of combination carboplatin/paclitaxel. Semin Oncol 24 Suppl. 2 (1997) 85-90